Acute renal failure complicating HELLP syndrome, SLE and anti-phospholipid syndrome: Successful outcome using plasma exchange therapy

Lupus

Volumn 12, Issue 4, 2003, Pages 251-257

  Roberts, G ^a,c   Gordon, M M ^a   Porter, D ^a   Jardine, A G ^b   Gibson, I W ^b  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

^c WISHAW GENERAL HOSPITAL   (United Kingdom)

Author keywords

Anti phospholipid syndrome; HELLP syndrome (haemolysis, elevated liver enzymes and low platelets); Plasma exchange; Systemic lupus erythematosis; TTP (thrombotic thrombocytopenic purpura)

Indexed keywords

ACETYLSALICYLIC ACID; ENOXAPARIN; WARFARIN;

ACUTE KIDNEY FAILURE; ADULT; ANTIPHOSPHOLIPID SYNDROME; BLOOD EXAMINATION; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DISEASE COURSE; FEMALE; HELLP SYNDROME; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LABORATORY TEST; PLASMAPHERESIS; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; ANTIPHOSPHOLIPID SYNDROME; BIOPSY; BRAIN; FEMALE; HELLP SYNDROME; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY GLOMERULUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; PLASMA EXCHANGE; PREGNANCY;

EID: 0037263005     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203303lu378xx     Document Type: Review

References (26)

1. Mintz G, Niz J, Gutierrez G et al. Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach. J Rheumatol 1986; 13(4): 732-739.
2. Kinciad-Smith P, Fairley KF, Kloss M. Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy related renal failure. Q J Med 1998; 258: 795-815.
3. Sibai BM, Ewall RJ, Levine RJ et al. Risk factors associated with preeclampsia in healthy nulliparous women. Am J Obstet Gynecol 1997; 177: 1003-1010.
4. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia - current concepts. Am J Obstet Gynecol 1998; 179: 1359-1375.
5. Lockwood CJ, Rand JH. The immunobiology and obstetrical consequences of the antiphospholipid antibody syndrome. Obstet Gynecol Surv 1994; 49(6) 432-441.
6. Sibai BM, Ramader MK, Usta I et al. Maternal morbidity and mortality in 442 pregnancies with haemolysis, elevated liver enzymes and low platelets (HELLP) syndrome. Am J Obstet Gynecol 1993; 169: 1000-1006.
7. Sibai BM, Ramadan MR. Acute renal failure in pregnancies complicated by Haemolysis, elevated liver enzymes and low platelets. Am J Obstet Gynecol 1993; 169: 1682-1687.
8. Martin JN J, Blake PG, Perry KG J et al. Natural history of the HELLP syndrome. Patterns of disease progression and regression. Am J Obstet Gynecol 1991; 164: 1500-1509.
9. Remucz G. HUS and TTP: variable expression of a single entity. Kidney Infect 1987; 32: 292-308.
10. Ezra Y, Rose M, Elder A. Therapy and prevention of thrombotic Thrombocytopenic purpura during pregnancy: a clinical study of 16 pregnancies. Am J Hematol 1996; 51: 1-6.
11. George JN, Gilcher RD Smith JW et al. Thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: diagnosis and management. J Clin Apheresis 1998; 13: 120-125.
12. Griffiths E, Dzik, WH. Assays for heparin-induced thrombocytopenia. Transfus Med 1997; 7: 1-11.
13. Chang, J. Postoperative thrombocytopenia: with etiologic, diagnostic, and therapeutic considerations. Am J Med Sci 1996; 311: 96-98.
14. Branch DW, Scott JR, Kochenour NK et al. Obstetric complications associated with the lupus anticoagulant. New Eng J Med 1985; 313: 1322-1326.
15. Lynch A, Marler R, Murphy J et al. Antiphospholipid antibodies in predicting adverse pregnancy outcomes. A prospective study. Ann Intern Med 1994; 120: 470-475.
16. Yasuda M, Takakuwa K, Tokunaga A, Tanaka K. Prospective studies of the associations between anticardiolipin antibody and the outcome of pregnancy. Obstet Gynecol 1995; 86: 555-559.
17. Lima F, Khamashta MA, Buchanan NM et al. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 1996; 14: 131.
18. Branch DW, Silver RM, Blackwell JL et al. Outcome of treated pregnancies in women with the antiphospholipid syndrome. Clin Exp Rheumatol 1992; 80: 614-616.
19. Out HJ, Bruinse HW, Christiaens GC et al. A prospective controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies. Am J Obstet Gynecol 1992; 167: 26-32.
20. Pattison NS, Chamley LW, Mckay EJ et al. Antiphospholipid antibodies in pregnancy. Prevalence and clinical associations. Br J Obstet Gynecol 1993; 100: 909-913.
21. Alsulyman DM, Casto MA, Zuckerman E et al. Preeclampsia and liver infarction in early pregnancy associated with the antiphospholipid syndrome. Obstet Gynecol 1996; 88: 644-646.
22. Piette JC, Cacoub P, Wechsher B. Renal manifestations of the antiphospholipid syndrome. Semin Arthritis Rheum 1994; 23: 357-366.
23. Amigo MC, Garcia-Torres R, Robles M et al. Renal involvement in the primary antiphospholipid syndrome. J Rheumatol 1992; 19: 1181-1185.
24. Amorosi EC, Ulymann JE. Thrombotic thrombocytopenic purpura. Report of 16 cases and review of the literature. Medicine (Balt) 1966; 45: 139-144.
25. Frampton G, Cameron JS, Thom M et al. Successful removal of anticardiolipin antibody during pregnancy using plasma exchange and low dose prednisolone. Lancet 1987; 21: 1023-1024.
26. Fulcher D, Stewart T, Exner T et al. Plasma exchange and the anticardiolipin syndrome in pregnancy. Lancet 1989; 2: 171.